VC firm

Samsara BioCapital

7 investors · 7 verified

Here are all investors at Samsara BioCapital.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Aditya AsokanAssociateSamsara BioCapitalUnited States1w ago
Abe BassanPrincipalSamsara BioCapitalUnited States1w ago
Marcos MillaVenture PartnerSamsara BioCapitalUnited States3w ago
John CurnutteAdvisorSamsara BioCapitalUnited States3w ago
Srini AkkarajuManaging PartnerSamsara BioCapitalUnited States3w ago
Mike DybbsPartnerSamsara BioCapitalUnited States3w ago
Cory FreedlandPrincipalSamsara BioCapitalUnited States4w ago

Browse all VCs

Recent investments at Samsara BioCapital

  • Link Cell TherapiesSeries A · $60M · 2025
  • Psivant TherapeuticsSeries A · $48M · 2025
  • Alpha-9 OncologySeries C · $180M · 2024
  • Enlaza TherapeuticsSeries A · $100M · 2024
  • Tentarix BiotherapeuticsSeries B · $35M · 2023
  • SepternaSeries B · $150M · 2023
  • ImmunOs TherapeuticsSeries B · $73M · 2022
  • ArcellxSeries C · $120M · 2021
  • Graphite BioSeries B · $150M · 2021
  • IonpathSeries B · $18M · 2020
  • Palvella TherapeuticsSeries C · $45M · 2020
  • Nkarta TherapeuticsSeries B · $110M · 2019

What founders say

4.1Based on 11 reviews